RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Clinical trials for RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough blood cancers: experimental drug APG-3288 enters human testing
Disease control Not yet recruitingThis early-stage study tests a new oral drug, APG-3288, in about 180 adults with blood cancers like leukemia or lymphoma that returned or didn't respond to prior treatments. The main goals are to find a safe dose and check for side effects. Researchers will also look for signs th…
Matched conditions: RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated May 17, 2026 07:38 UTC
-
New hope for tough blood cancers: experimental drug QLS2313 enters first human trial
Disease control Not yet recruitingThis early-stage trial tests a new drug called QLS2313 in 124 adults with blood cancers (like lymphoma or leukemia) that have returned or stopped responding to standard treatments. The main goals are to check the drug's safety, find the right dose, and see if it can shrink tumors…
Matched conditions: RELAPSED/REFRACTORY HEMATOLOGICAL MALIGNANCIES
Phase: PHASE1 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 07:34 UTC